Dr. Ragini Verma's lab at the University of Pennsylvania focuses on improving surgical outcomes for patients with high-grade gliomas, a type of aggressive brain cancer. The lab is developing innovative tools that use advanced imaging techniques to help surgeons accurately locate and remove both visible and infiltrative tumor tissue while preserving important brain functions. This research aims to increase survival rates for patients by enhancing pre-operative planning and minimizing neurological deficits after surgery.

Dr. Chun-Yuh Huang's lab at the University of Miami focuses on understanding the causes of intervertebral disc degeneration, a key contributor to low back pain, which affects millions of people. The lab investigates how factors like aging and inflammation impact the metabolism of disc cells and the production of essential components like proteoglycans. By combining laboratory experiments, patient studies, and computational models, the team aims to identify new therapeutic targets and improve diagnostic methods for disc degeneration.

Dr. Neema Jamshidi's research lab at UCLA focuses on improving our understanding and treatment of pancreatic cancer, a highly aggressive type of cancer with poor survival rates. The lab integrates various diagnostic techniques, including imaging and molecular profiling, to identify distinct characteristics of the tumor environment. By combining data from multiple sources, they aim to create non-invasive imaging tests for better diagnosis and potential new treatment targets.

Dr. Kevin A. Janes' research lab at the University of Virginia focuses on understanding viral infections and their impact on human health, specifically through innovative computational models and genetic analyses. They also explore the origins and progression of basal-like breast cancer, which is known for its aggressive nature and poor prognosis. By combining advanced modeling techniques with genetically engineered mouse models, the lab aims to uncover critical insights into both viral and cancer biology.

Dr. Quan Jiang's lab focuses on understanding how the brain clears waste products, especially in conditions like diabetes and Alzheimer’s disease. The team investigates the connections between the brain's waste clearance systems and cognitive decline, employing advanced imaging techniques to observe these processes in real-time. This research aims to uncover mechanisms that could help slow or prevent the progression of neurodegenerative diseases.

Dr. Wen Jiang's lab focuses on innovative cancer immunotherapy techniques, particularly using macrophages to target solid tumors like breast cancer and glioblastoma. The research aims to engineer macrophages in vivo to enhance their ability to fight tumors by using mRNA-loaded exosomes, which may simplify current cell therapy methods. This work is significant as it seeks to overcome challenges in traditional CAR T cell therapies, making cancer treatments more effective.

Dr. Kamariza's lab focuses on developing innovative diagnostic tools to tackle tuberculosis, particularly drug-resistant strains. By creating a new rapid drug susceptibility test, the lab aims to improve the identification of TB and its resistance to treatments, especially in low-resource settings. This research is crucial for enhancing global healthcare responses to tuberculosis, a leading infectious disease threat.

Dr. Alexey Kamenskiy's lab at the University of Nebraska Omaha focuses on finding innovative solutions for patients with Peripheral Artery Disease (PAD) that often leads to severe complications like amputation. The lab is developing a new method using a microneedle catheter to deliver a chelating agent called EDTA directly to calcified lesions in arteries to remove arterial calcium. This research aims not only to improve the safety and effectiveness of treatments for PAD but also to enhance the quality of life for affected individuals.

Dr. Joel S. Karp's lab at the University of Pennsylvania focuses on enhancing cancer imaging techniques using advanced PET (Positron Emission Tomography) and CT (Computed Tomography) technologies. The research aims to develop innovative scan protocols and detector designs to improve diagnostic accuracy while reducing patient burden through shorter imaging times. By integrating dynamic imaging methods, the lab seeks to provide better insights into cancer biology and improve patient outcomes via enhanced imaging protocols.

Dr. Galateia J Kazakia's research lab focuses on understanding bone health in patients with chronic kidney disease (CKD) and those recovering from fractures. The lab is exploring innovative, non-invasive methods to assess bone turnover, which is critical for managing fracture risk. By using advanced imaging techniques, the lab aims to improve patient care and develop strategies to prevent fractures, especially in older patients.

Dr. Sarah Kerns' lab focuses on improving how prostate cancer patients are treated with radiotherapy by using advanced machine learning techniques to predict potential side effects. They aim to identify patients at risk for severe complications from treatment, which commonly affect quality of life. This research not only helps in personalizing cancer treatment but also explores the genetic factors that contribute to these adverse effects, paving the way for better patient care and therapeutic interventions.

Dr. Salman Khetani's lab at the University of Illinois at Chicago focuses on understanding and treating non-alcoholic fatty liver disease (NAFLD) by studying how different components of the liver's environment influence the behavior of liver cells. The lab creates engineered systems that mimic the liver environment, allowing researchers to discover how changes in cell composition and stiffness affect liver cell function and disease progression. Their ultimate goal is to develop new therapies to combat liver diseases that are becoming increasingly prevalent.

Dr. Alex Hughes' lab at the University of Pennsylvania focuses on developing engineered kidney tissues by manipulating stem cells to produce nephrons in a controlled, rhythmic manner. The research aims to understand the natural processes that facilitate kidney development and replicate those mechanisms in lab-grown tissues. By improving the scale and efficiency of nephron production, this work has the potential to revolutionize treatments for kidney failure and related diseases.

Dr. Ana Ponce Kiess leads a research lab that focuses on improving cancer therapies through advanced radiation techniques. The lab aims to develop methods for dosimetry which can more precisely measure radiation doses delivered during alpha-particle emitter radiopharmaceutical therapy. This research is particularly aimed at treating metastatic cancer while minimizing harmful side effects. By enhancing treatment planning, Dr. Kiess's lab seeks to improve survival rates for patients with difficult-to-treat cancers.

Dr. Deok-Ho Kim's lab at Johns Hopkins University focuses on developing innovative in vitro models to study complex diseases such as Parkinson's and cardiac conditions. They utilize advanced microphysiological systems to replicate human tissue environments and investigate how disease mechanisms affect neural and cardiac function. The aim is to improve understanding of disease pathways and evaluate potential therapeutic strategies using patient-specific cells.

Dr. Kimple's lab focuses on improving models used to study head and neck cancer by examining how different methods of implanting patient tumors in mice affect the accuracy and relevance of research findings. This work helps ensure that treatments tested in these models are more predictive of their effects in actual patients. By exploring the interactions between tumors and the immune system, the lab aims to enhance the development of novel therapies for head and neck cancer patients.

Dr. Paul E. Kinahan's lab at the University of Washington focuses on improving cancer detection and treatment through advanced imaging technologies. They work on optimizing positron emission tomography (PET) imaging to better identify and characterize early-stage cancers, particularly in breast cancer therapy. The lab employs cutting-edge techniques, including machine learning and advanced imaging algorithms, to enhance diagnostic accuracy and potentially save lives by allowing earlier interventions.

Dr. Natalia Kleinhans's lab investigates how cannabis exposure during pregnancy affects infant brain development and behavior. By using advanced imaging techniques and neurobehavioral assessments, the lab aims to identify risks associated with prenatal cannabis use, especially given the increasing legalization and changing public perceptions of cannabis. Their research focuses on understanding neurodevelopmental changes in infants whose mothers used cannabis during pregnancy, aiming to inform public health policies and parental choices.

Dr. Ravinder Regatte's lab at NYU focuses on improving the diagnosis of osteoarthritis through advanced MRI techniques. By developing a method called magnetic resonance fingerprinting (MRF), the lab aims to quickly and accurately assess knee joint health without the need for contrast agents. This work not only benefits patients by providing earlier diagnosis but also aims to enhance treatment strategies for osteoarthritis.

Dr. Takashi Daniel Yoshida Kozai's lab at the University of Pittsburgh focuses on advancing technologies for brain stimulation and understanding brain responses to chronic implants. The lab is working on innovative electrode designs that aim to enhance the precision of stimulating brain cells, which could improve treatments for neurological disorders. Additionally, the research investigates how specific brain cells called oligodendrocytes affect the performance of brain implants over time, aiming to gain insights that could benefit both basic neuroscience and clinical applications.